Santa Barbara, CA (Scicasts) - Researchers at UC Santa Barbara demonstrate the synthesis of nanosize biological particles with the potential to fight cancer and other illnesses. The studies introduce new approaches that are considered "green" nanobiotechnology because they use no artificial compounds.

Dresden, Germany (Scicasts) - Transinsight, provider of semantic search technologies, releases the next version of its Enterprise Semantic Intelligence Knowledge Suite at the I-SEMANTICS Conference in Graz, Austria.

Tokyo, Japan (Scicasts) - World Fusion, the Japanese informatics management firm, today announced the creation of a sequence analysis service center with a bioinformatics infrastructure based on CLC bio's enterprise platform for high-throughtput sequencing data analysis, coupled with World Fusion's own Life Science Knowledge Bank (LSKB) bio knowledge database system.

Boston, MA (Scicasts) – Researchers at Beth Israel Deaconess Medical Center (BIDMC) have uncovered the genes that regulate MDM2, an oncogene that, in turn, regulates the tumour suppressor protein p53. But instead of an on-off switch for MDM2, the team found what looks like a dimmer switch, suggesting a more complicated signalling pathway that is sensitive to a changing environment.

Blacksburg, VA (Scicasts) - A software package developed by a professor at the Virginia Bioinformatics Institute (VBI) and his colleagues to help researchers better understand the workings of biochemical networks now features an open source license, offering an ever wider range of benefits to its users.

San Francisco, CA (Scicasts) - Genedata, a provider of advanced software solutions for drug discovery and life science research, has announced Genedata Selector, a new solution for biotechnological strain development in fermentation-based applications. The latest addition to the Genedata portfolio, Genedata Selector is an integrated data management and analysis system specifically for industrial biotechnology R&D. It supports industrial biotechnology production of feed and food additives, fine chemicals, biofuels, and personal care, pharmaceutical, and agrochemical products.

Rochester, NY (Scicasts) - Digital archives of biomedical images could someday put critical information at doctors' fingertips within seconds, illustrating how computers can improve the way medicine is practiced. The current reality, however, isn't quite up to speed, with databases virtually overwhelmed by the explosion of medical imaging.

London, UK (Scicasts) - Researchers funded by the Medical Research Council (MRC) have discovered for the first time that two proteins called Mahjong and Lgl could be star players in helping to identify how the body's own cells fight back against cancer cells. This discovery, published July 13, 2010 in the online, open-access journal PLoS Biology, could lead to future treatments to make our healthy cells better-equipped to attack cancer cells, an entirely new concept for cancer research.

San Diego, CA (scicasts) - Accelrys and Symyx Technologies have announced Merger completion. According to the announcement, the combined entity enables customers to improve scientific performance by creating more open, flexible and agile environments, streamlining workflows, reducing operating costs, and increasing the potential for innovation.

München, Germany (Scicasts) - Eurofins MWG Operon, a next generation sequencing (NGS) Company and Genomatix Software GmbH, a company involved in complex analysis and interpretation of such NGS data, have announced their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

Phoenix, AZ (Scicasts) – According to a report from Translational Genomics Research Institute (Tgen), researchers at the Institute have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

New York (Scicasts) - A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Center (MSKCC) has yielded the most comprehensive genomic analysis of prostate cancer to date, according to a report from the Center. "Genomic studies in other cancer types have resulted in new drug targets and strategies to classify patients into clinically meaningful subgroups that improve treatment decisions," said senior study author Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at MSKCC and a HHMI investigator. "This first -ever database of its type brings us one step closer to achieving that goal in prostate cancer."

Guildford, UK, and Burlington, MA (Scicasts) - IDBS, a worldwide provider of research data management and analytics solutions to R&D organizations, has announced innovative new one-click Microsoft Word publishing functionality in its E-WorkBook Suite. One-click publishing capabilities enable rapid generation of complex reports, particularly those requiring regulatory compliance, including investigational new drug (IND) reports, new drug applications (NDAs), biologics license applications (BLAs), study reports, and validation reports.

Carlsbad, CA and Heidelberg, Germany (Scicasts) - Life Technologies and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) have announced their collaboration to create the National High-Throughput Sequencing Center. According to the announcement, this exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing centre in Europe dedicated to systems biology.

St. Louis, MO (Scicasts) - According to a report from the Washington University School of Medicine in St. Louis, the bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery.

Hinxton, UK (Scicasts) - According to a report from the Wellcome Trust Sanger Institute, a team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.

La Jolla, CA (Scicasts) - Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.

Quebec, Canada (Scicasts) - In a major cancer-research breakthrough, researchers at the McGill University, Department of Biochemistry have discovered that a small segment of a protein that interacts with RNA can control the normal expression of genes – including those that are active in cancer.

Ann Arbor, MI (Scicasts) - Prostate cancer treatments that target the hormone androgen and its receptor may be going after the wrong source, according to a new study. Researchers have found that when two genes fuse together to cause prostate cancer, it blocks the receptor for the hormone androgen, preventing prostate cells from developing normally.

Yokohama, Japan and Aarhus, Denmark (Scicasts) - RIKEN and CLC bio Japan have announced an agreement for the purchase of CLC bio’s enterprise platform software by RIKEN Omics Science Center (OSC). According to the announcement, CLC bio’s high-throughput sequence analysis infrastructure will empower both OSC's scientists and OSC’s Genome Network Analysis Service (GeNAS) with a user-friendly and fast workflow to efficiently manage and analyze large quantities of genomics data.